About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: April 2012
FDA Sends Out 10 Warning Letters to Dietary Supplement Manufacturers
10 Count ’em 10. That is how many Warning Letters the agency sent out last Friday to manufacturers and distributors of dietary supplements. The specific focus of the letters was products that were being marketed containing dimethylamylamine, also known as … Continue reading
Posted in Warning Letters
Comments Off on FDA Sends Out 10 Warning Letters to Dietary Supplement Manufacturers
Weekly Roundup – 4/27/12 – Back in the Saddle
Lately I have been on hiatus. It was not a planned one, but brought on by a convergence of circumstances that I’m happy to say includes being extremely busy. That said, I have missed writing my postings and have stored … Continue reading
Posted in Weekly Roundup
3 Comments
Seeking Transparency on Sunshine Act
Yesterday Senators Kohl and Grassley submitted a letter to CMS seeking information on the implementation of the Sunshine Act – the legislation passed and signed into law that would put into place a system for public reporting of the financial … Continue reading
Posted in Industry Image
Comments Off on Seeking Transparency on Sunshine Act